December 19, 2017 / 7:54 AM / 6 months ago

BRIEF-Ose Immunotherapeutics Presents New Data Analysis About Ose-127

Dec 19 (Reuters) - OSE IMMUNOTHERAPEUTICS SA:

* OSE IMMUNOTHERAPEUTICS PRESENTS NEW DATA ANALYSIS SUPPORTING CONTINUED DEVELOPMENT OF OSE-127 IN INFLAMMATORY BOWEL DISEASES

* OSE-127 SHOWN TO HAVE SIGNIFICANT POTENTIAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)

* OVEREXPRESSION OF IL-7R IN COLON PREDICTING A NON-RESPONSE TO ANTI-TNFΑ THERAPY.

* ‍OVEREXPRESSION OF IL-7R IN COLON PREDICTING A NON-RESPONSE TO ANTI-TNFΑ THERAPY​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below